Gossamer Bio, Inc. (GOSS)
9.79
+0.21
(+2.19%)
USD |
NASDAQ |
Oct 21, 16:00
9.80
+0.01
(+0.10%)
After-Hours: 20:00
Gossamer Bio Net Income (Annual) : -170.37M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -170.37M |
| December 31, 2024 | -56.53M |
| December 31, 2023 | -179.82M |
| December 31, 2022 | -229.38M |
| December 31, 2021 | -234.00M |
| Date | Value |
|---|---|
| December 31, 2020 | -243.36M |
| December 31, 2019 | -180.31M |
| December 31, 2018 | -146.97M |
| December 31, 2017 | -6.771M |
| December 31, 2016 | -0.083M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| United Therapeutics Corp. | 1.335B |
| Arbutus Biopharma Corp. | -33.50M |
| Kura Oncology, Inc. | -278.67M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |